We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prediction of outcome of extracorporeal shock wave lithotripsy in the management of ureteric calculi.
- Authors
Wang, Mingqing; Shi, Qiduo; Wang, Xuguang; Yang, Kun; Yang, Rui
- Abstract
The present study was designed to evaluate the clinical outcome of using extracorporeal shock wave lithotripsy (ESWL) in the treatment of ureteric calculi and to establish a predictive model for the stone-free rate in patients receiving the treatment. A total of 831 patients with ureteric calculi were accepted in this study. Several parameters, including stone site, stone number, stone size, history of urolithiasis, renal colic, hydronephrosis, and double-J ureteric stent, were analyzed using univariate and multivariate analyses. A prediction model was established based on the logistic regression analysis of the significant factors, and the goodness-of-fit of the model was evaluated by employing the Hosmer-Lemeshow test. At a 3-month follow-up after ESWL treatment, the overall stone-free rate was 96.8% (804/831) with no serious complications being found, while the treatment failed in 3.2% (27/831) of the patients. Five factors, including stone number, stone size, history of urolithiasis, renal colic, and double-J ureteric stent contributed significantly to the clinical outcome of the ESWL treatment. The prediction model had a sensitivity and overall accuracy of 99.8 and 96.9%, respectively. The results show that ESWL remains an effective method for treating ureteric calculi. The prediction model established in this study could be used as a method for estimating prognosis in patients following ESWL treatment.
- Subjects
EXTRACORPOREAL shock wave lithotripsy; URETERIC obstruction; URINARY calculi; TREATMENT effectiveness; PREDICTION models; LOGISTIC regression analysis; MULTIVARIATE analysis
- Publication
Urological Research, 2011, Vol 39, Issue 1, p51
- ISSN
0300-5623
- Publication type
Article
- DOI
10.1007/s00240-010-0274-5